Ascentage Pharma Group International (AAPG) Total Current Liabilities (2023 - 2026)

Ascentage Pharma Group International's Total Current Liabilities history runs 3 years deep, the most recent figure standing at $231.7 million for Q4 2025.

• In Q4 2025, Total Current Liabilities rose 42.67% year-over-year to $231.7 million; the TTM figure through Dec 2025 stood at $231.7 million (up 42.67% YoY), while the FY2025 annual figure was $235.0 million, up 47.04% from the prior year.
• Total Current Liabilities for Q4 2025 stood at $231.7 million, down from $252.2 million in the prior quarter.
• The five-year high for Total Current Liabilities was $252.2 million in Q2 2025, with the low at $129.7 million in Q4 2023.
• The 3-year median for Total Current Liabilities is $197.1 million (2024), against an average of $194.0 million.
• The sharpest annual moves came in 2024 and 2025: Total Current Liabilities increased 25.18% in 2024, then soared 42.67% in 2025.
• Ascentage Pharma Group International's Total Current Liabilities stood at $129.7 million in 2023, then climbed by 25.18% to $162.4 million in 2024, then jumped by 42.67% to $231.7 million in 2025.
• Business Quant data shows AAPG's Total Current Liabilities at $231.7 million in Q4 2025, $252.2 million in Q2 2025, and $162.4 million in Q4 2024.